<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/5961</identifier>
				<datestamp>2020-04-10T16:56:12Z</datestamp>
				<setSpec>aabp:Abs</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Lung Lesions in Feeder Cattle at Slaughter: A Proposed Method for Lesion Recording, and Lesion Effects on Calf Growth and Carcass Traits</dc:title>
	<dc:creator xml:lang="en">Bryant, Lonty K.</dc:creator>
	<dc:creator xml:lang="en">Perino, Louis J.</dc:creator>
	<dc:creator xml:lang="en">Griffin, D. Dee</dc:creator>
	<dc:creator xml:lang="en">Doster, Alan R.</dc:creator>
	<dc:creator xml:lang="en">Dewey, Catherine E.</dc:creator>
	<dc:creator xml:lang="en">Whittum, Thomas E.</dc:creator>
	<dc:subject xml:lang="en">clinical pneumonia</dc:subject>
	<dc:subject xml:lang="en">performance</dc:subject>
	<dc:subject xml:lang="en">pharmaceutical efficacy</dc:subject>
	<dc:subject xml:lang="en">vaccine efficacy</dc:subject>
	<dc:subject xml:lang="en">management</dc:subject>
	<dc:subject xml:lang="en">environment</dc:subject>
	<dc:subject xml:lang="en">disease occurrence</dc:subject>
	<dc:subject xml:lang="en">lesions</dc:subject>
	<dc:description xml:lang="en">Decreased growth in beef calves with clinical pneumonia is reported in veterinary literature. Conversely, several studies found no impact on mean daily gain (MDG) between calves that develop clinical disease and those that do not. Explaining the published discrepancies concerning the effects of pneumonia on growth and performance is necessary to understand its true financial impact. Additional studies are needed to develop methods of detecting clinical or asymptomatic disease. Vaccine and pharmaceutical efficacy studies traditionally have been conducted using mortality and morbidity as the outcomes of interest. These are important parameters, but as pilot studies show,1 asymptomatic disease can be equally significant on calf growth and possibly carcass traits.
Evaluation of animal interaction with management, environment, and disease occurrence plus evaluation of lesions at slaughter should provide new information on disease development and may lead to a better understanding of the respiratory disease process and its cost. Standardized methods of recording and investigating each lesion's significance on calf growth and carcass traits are needed.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>1996-09-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/aabp/article/view/5961</dc:identifier>
	<dc:identifier>10.21423/aabppro19965961</dc:identifier>
	<dc:source xml:lang="en">American Association of Bovine Practitioners  Conference Proceedings; 1996; 147-151</dc:source>
	<dc:source>1079-9737</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/aabp/article/view/5961/5773</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1996 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
